OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
Jiayi Gu, Xueling Wang, Yuming Chen, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss
Winston Tan, Lei Song
Hearing Research (2023) Vol. 434, pp. 108783-108783
Closed Access | Times Cited: 66

Recent progress of nanomaterials for colorimetric and fluorescence sensing of reactive oxygen species in biological and environmental samples
Suresh Kumar Kailasa, Ghinaiya Nirav Vajubhai, Janardhan Reddy Koduru, et al.
Trends in Environmental Analytical Chemistry (2023) Vol. 37, pp. e00196-e00196
Closed Access | Times Cited: 46

Micro-algal astaxanthin improves lambda-cyhalothrin-induced necroptosis and inflammatory responses via the ROS-mediated NF-κB signaling in lymphocytes of carp (Cyprinus carpio L.)
Jingzeng Cai, Pinnan Liu, Xintong Zhang, et al.
Fish & Shellfish Immunology (2023) Vol. 139, pp. 108929-108929
Closed Access | Times Cited: 39

Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage
Jintao Lou, Fan Wu, Wuhui He, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9

An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management
Caroline Assunção Oliveira, Érika Azenathe Barros Mercês, Fernanda Santos Portela, et al.
Clinical and Experimental Nephrology (2024) Vol. 28, Iss. 8, pp. 711-727
Closed Access | Times Cited: 9

Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target?
Jelena Katanić, Dragica Selaković, Gvozden Rosić
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14574-14574
Open Access | Times Cited: 20

Cisplatin ototoxicity mechanism and antagonistic intervention strategy: a scope review
Yingru Li, Tianyang Zhang, Qiang Song, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 19

Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss
Ke Xu, Baoying Xu, Jiayi Gu, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3524-3549
Open Access | Times Cited: 19

Dual stimuli-responsive and sustained drug delivery NanoSensoGel formulation for prevention of cisplatin-induced ototoxicity
Neeraj S. Thakur, Iulia Rus, Ethan Sparks, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 66-83
Closed Access | Times Cited: 6

Nuciferine Protects Cochlear Hair Cells from Ferroptosis through Inhibiting NCOA4-Mediated Ferritinophagy
Xianhua Gao, Huanyu Mao, Liping Zhao, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 714-714
Open Access | Times Cited: 6

A core-shell-type nanosystem promotes diabetic wound healing through Photothermal-responsive release of transforming growth factor β
Jinfei Hou, Junjin Jie, Xinwei Wei, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

The Blood-Labyrinth Barrier: Non-Invasive Delivery Strategies for Inner Ear Drug Delivery
Zhangyi Yi, Xiaoying Wang, Ge Yin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 482-482
Open Access

Gelatin‐Encapsulated Tetrahedral DNA Nanostructure Enhances Cellular Internalization for Treating Noise‐Induced Hearing Loss
Ke Xu, Yiwei Du, Baoying Xu, et al.
Small (2024) Vol. 20, Iss. 26
Closed Access | Times Cited: 3

Apoptosis, autophagy, ferroptosis, and pyroptosis in cisplatin-induced ototoxicity and protective agents
Dingyuan Dai, Chao Chen, Lu Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Space Station-like Composite Nanoparticles for Co-Delivery of Multiple Natural Compounds from Chinese Medicine and Hydrogen in Combating Sensorineural Hearing Loss
Wenbin Xiao, Kerui He, Chong Yu, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3987-4006
Closed Access | Times Cited: 8

Cutting‐Edge Achievements of Inner Ear Drug Delivery Systems
Hui Zhang, Dongyu Xu, Huan Wang, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 2

The antioxidant ergothioneine alleviates cisplatin-induced hearing loss through the Nrf2 pathway
Wenji Zhao, Fan Wu, Rui Hu, et al.
Antioxidants and Redox Signaling (2024)
Closed Access | Times Cited: 2

Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss
Zeinab Hajmohammadi, Zohreh Bagher, Farzad Taghizadeh‐Hesary, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 202, pp. 114393-114393
Closed Access | Times Cited: 2

Magnetic/Acoustic Dual‐Controlled Microrobot Overcoming Oto‐Biological Barrier for On‐Demand Multidrug Delivery against Hearing Loss
Xinyang Yi, Lifang Guo, Qi Zeng, et al.
Small (2024) Vol. 20, Iss. 44
Closed Access | Times Cited: 2

Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy—A State-of-the-Art Review
Olaf Rose, Tim Croonenberg, Stephanie Clemens, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1578-1578
Open Access | Times Cited: 1

Harnessing astaxanthin-loaded diselenium cross-linked apotransferrin nanoparticles for the treatment of secretory otitis media
Siqi Yang, Yanxian Wu, Xiaju Cheng, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 398-411
Closed Access | Times Cited: 2

Engineered Fenofibrate as Oxidation-Sensitive Nanoparticles with ROS Scavenging and PPARα-Activating Bioactivity to Ameliorate Nonalcoholic Fatty Liver Disease
Kaiyue Du, Xin Huang, Ankang Peng, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 1, pp. 159-171
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top